Suppr超能文献

与术后第 1 天的淀粉酶值相比,术后引流液淀粉酶的变化趋势更能准确预测胰十二指肠切除术后发生临床相关胰瘘的风险。

The risk of clinically-relevant pancreatic fistula after pancreaticoduodenectomy is better predicted by a postoperative trend in drain fluid amylase compared to day 1 values in isolation.

机构信息

Department of Surgery, University of Pittsburgh Medical Center, PA.

Wolff Center at University of Pittsburgh Medical Center, PA.

出版信息

Surgery. 2023 Oct;174(4):916-923. doi: 10.1016/j.surg.2023.06.009. Epub 2023 Jul 17.

Abstract

BACKGROUND

Recent studies support early drain removal after pancreaticoduodenectomy in patients with a drain fluid amylase on postoperative day 1 (DFA1) level of ≤5,000. The use of DFA1 to guide drain management is increasingly common among pancreatic surgeons; however, the benefit of checking additional drain fluid amylases beyond DFA1 is less known. We sought to determine whether a change in drain fluid amylase (ΔDFA) is a more reliable predictor of clinically relevant postoperative fistula than DFA1 alone.

METHODS

Using the American College of Surgeons National Surgical Quality Improvement Plan, pancreaticoduodenectomy patients with intraoperative drain placement, known DFA1, highest recorded drain fluid amylase value on postoperative day 2 to 5 (DFA2nd), day of drain removal, and clinically relevant postoperative fistula status were reviewed. Logistic models compared the predictive performance of DFA1 alone versus DFA1 + ΔDFA.

RESULTS

A total of 2,417 patients with an overall clinically relevant postoperative fistula rate of 12.6% were analyzed. On multivariable regression, clinical predictors for clinically relevant postoperative fistula included body mass index, steroid use, operative time, and gland texture. These variables were used to develop model 1 (DFA1 alone) and model 2 (DFA1 + ΔDFA). Model 2 outperformed model 1 in predicting the risk of clinically relevant postoperative fistula. According to model 2 predictions, the risk of clinically relevant postoperative fistula increased with any rise in drain fluid amylase, regardless of whether the DFA1 was above or below 5,000 U/L. The risk of clinically relevant postoperative fistula significantly decreased with any drop in drain fluid amylase, with an odds reduction of approximately 50% corresponding with a 70% decrease in drain fluid amylase (P < .001). A risk calculator was developed using DFA1 and a secondary DFA value in conjunction with other clinical predictors for clinically relevant postoperative fistula.

CONCLUSION

Clinically relevant postoperative fistula after pancreaticoduodenectomy is more accurately predicted by DFA1 and ΔDFA versus DFA1 in isolation. We developed a novel risk calculator to provide an individualized approach to drain management after pancreaticoduodenectomy.

摘要

背景

最近的研究支持在胰十二指肠切除术后第 1 天(DFA1)引流液淀粉酶水平≤5000 的患者中尽早拔除引流管。使用 DFA1 指导引流管理在胰腺外科医生中越来越普遍;然而,检查 DFA1 以外的其他引流液淀粉酶的益处知之甚少。我们旨在确定引流液淀粉酶的变化(ΔDFA)是否比单独的 DFA1 更能可靠预测临床相关的术后瘘。

方法

利用美国外科医师学院国家手术质量改进计划,回顾了术中放置引流管、已知 DFA1、术后第 2 至 5 天(DFA2nd)记录的最高引流液淀粉酶值、引流管拔除日期和临床相关术后瘘的胰十二指肠切除术后患者。Logistic 模型比较了 DFA1 单独与 DFA1+ΔDFA 的预测性能。

结果

共分析了 2417 例总体临床相关术后瘘发生率为 12.6%的患者。多变量回归分析显示,临床相关术后瘘的预测因素包括体重指数、类固醇使用、手术时间和腺体质地。这些变量用于开发模型 1(DFA1 单独)和模型 2(DFA1+ΔDFA)。在预测临床相关术后瘘的风险方面,模型 2 优于模型 1。根据模型 2 的预测,无论 DFA1 高于或低于 5000 U/L,任何升高的引流液淀粉酶都会增加临床相关术后瘘的风险。任何降低的引流液淀粉酶都会显著降低临床相关术后瘘的风险,与引流液淀粉酶降低 70%对应的优势比降低约 50%(P<.001)。使用 DFA1 和次要 DFA 值以及其他临床预测因素,为临床相关术后瘘开发了一个风险计算器。

结论

与单独的 DFA1 相比,DFA1 和 ΔDFA 更能准确预测胰十二指肠切除术后的临床相关术后瘘。我们开发了一种新的风险计算器,为胰十二指肠切除术后的引流管理提供了一种个体化的方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验